Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sino Biopharmaceutical Ltd (HK:1177)
HKEX:1177
Holding HK:1177?
Track your performance easily
1177 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$2.29 - HK$3.89
Previous CloseHK$3.28
Volume32.58M
Average Volume (3M)47.72M
Market Cap
HK$61.37B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)23.4
Beta0.98
Next Earnings
Mar 28, 2025EPS Estimate
HK$0.08Last Dividend Ex-Date
Sep 10, 2024Dividend Yield1.5%
Share Statistics
EPS (TTM)0.14
Shares OutstandingN/A
10 Day Avg. Volume39,424,835
30 Day Avg. Volume47,716,282
Standard Deviation0.10
R-Squared0.23
Alpha-0.00410
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$6.00Price Target Upside83.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Sino Biopharmaceutical News
PremiumCompany Announcements
Sino Biopharmaceutical’s Promising Cancer Drug Results
PremiumCompany Announcements
Sino Biopharm Unveils Promising Cancer Drug Results
PremiumCompany Announcements
Sino Biopharmaceutical’s Breakthrough in Breast Cancer Treatment
PremiumCompany Announcements
Sino Biopharmaceutical’s Breakthrough in Liver Cancer Treatment
PremiumCompany Announcements
Sino Biopharmaceutical Unveils Respiratory Drug BreakthroughsPremiumCompany Announcements
Sino Biopharmaceutical Declares Interim Dividend
PremiumCompany Announcements
Sino Biopharmaceutical Posts Robust H1 2024 Growth
PremiumCompany Announcements
Sino Biopharmaceutical Targets Advanced RCCOptions Prices
Currently, No data available
---
Ownership Overview
15.58% Insiders
2.48% Mutual Funds
4.82% Other Institutional Investors
77.13% Public Companies and
Individual Investors
1177 FAQ
What was Sino Biopharmaceutical Ltd’s price range in the past 12 months?
Sino Biopharmaceutical Ltd lowest stock price was HK$2.29 and its highest was HK$3.89 in the past 12 months.
What is Sino Biopharmaceutical Ltd’s market cap?
Currently, no data Available
When is Sino Biopharmaceutical Ltd’s upcoming earnings report date?
Sino Biopharmaceutical Ltd’s upcoming earnings report date is Mar 28, 2025 which is in 189 days.
How were Sino Biopharmaceutical Ltd’s earnings last quarter?
Sino Biopharmaceutical Ltd released its earnings results on Aug 13, 2024. The company reported HK$0.085 earnings per share for the quarter, beating the consensus estimate of HK$0.077 by HK$0.008.
Is Sino Biopharmaceutical Ltd overvalued?
According to Wall Street analysts Sino Biopharmaceutical Ltd’s price is currently Undervalued.
Does Sino Biopharmaceutical Ltd pay dividends?
Sino Biopharmaceutical Ltd pays a Annually dividend of HK$0.03 which represents an annual dividend yield of 1.5%. See more information on Sino Biopharmaceutical Ltd dividends here
What is Sino Biopharmaceutical Ltd’s EPS estimate?
Sino Biopharmaceutical Ltd’s EPS estimate is HK$0.08.
How many shares outstanding does Sino Biopharmaceutical Ltd have?
Sino Biopharmaceutical Ltd has 18,791,217,000 shares outstanding.
What happened to Sino Biopharmaceutical Ltd’s price movement after its last earnings report?
Sino Biopharmaceutical Ltd reported an EPS of HK$0.085 in its last earnings report, beating expectations of HK$0.077. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sino Biopharmaceutical Ltd?
Currently, no hedge funds are holding shares in HK:1177
---
Sino Biopharmaceutical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.58%
12-Months-Change
Fundamentals
Return on Equity
6.54%
Trailing 12-Months
Asset Growth
1.59%
Trailing 12-Months
Company Description
Sino Biopharmaceutical Ltd
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong.
---
1177 Stock 12 Month Forecast
Average Price Target
HK$6.00
▲(83.01% Upside)
Technical Analysis
Best Analysts Covering 1177
1 Year
---